Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

TFIIIB90 Inhibitors

TFIIIB90 inhibitors belong to a specialized category of chemical compounds that have garnered attention in the field of molecular biology and gene transcription. TFIIIB90, also known as TBP-associated factor 90 kDa subunit (TAF12), is a subunit of the Transcription Factor IIIB (TFIIIB) complex. TFIIIB is an essential component of the eukaryotic transcription machinery, responsible for recruiting RNA polymerase III to specific gene promoters, thereby initiating the transcription of genes involved in essential cellular processes, including the synthesis of transfer RNAs (tRNAs) and other non-coding RNAs. TFIIIB90 inhibitors are chemical compounds designed to interact with TFIIIB90, potentially modulating its role in the assembly and function of the TFIIIB complex, ultimately influencing the transcription of RNA polymerase III-dependent genes.

The mechanism of action of TFIIIB90 inhibitors typically involves their binding to TFIIIB90, often at specific binding sites or domains that are critical for its interactions within the TFIIIB complex. This interaction can lead to changes in the ability of TFIIIB90 to participate in the recruitment of RNA polymerase III to gene promoters, potentially affecting the transcription of genes involved in processes like tRNA synthesis. Consequently, TFIIIB90 inhibitors may have implications for various cellular processes that rely on the proper transcription of RNA polymerase III-dependent genes, offering insights into the molecular mechanisms that govern gene expression and its regulation. The study of TFIIIB90 inhibitors is instrumental in advancing our understanding of transcription initiation, providing valuable tools for investigating the roles of TFIIIB90 in various cellular contexts and its impact on the synthesis of essential non-coding RNAs.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide is known to inhibit RNA polymerase II activity, potentially affecting the transcription of genes including those coding for transcription factors.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and potentially downregulating various transcriptional processes.

Mitoxantrone

65271-80-9sc-207888
100 mg
$279.00
8
(1)

Mitoxantrone intercalates into DNA and inhibits topoisomerase II, potentially affecting transcription and expression of certain genes.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol is a cyclin-dependent kinase inhibitor that may indirectly affect transcription factor expression through cell cycle regulation.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB inhibits RNA polymerase II transcription elongation, potentially impacting TFIIIB90 expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA synthesis, potentially affecting the expression of a wide variety of genes.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

This compound inhibits RNA polymerase II, potentially leading to decreased transcription of various genes including transcription factors.

Oxaliplatin

61825-94-3sc-202270
sc-202270A
5 mg
25 mg
$110.00
$386.00
8
(1)

Oxaliplatin forms DNA adducts that can lead to transcription inhibition, possibly affecting genes such as TFIIIB90.

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

BMH-21 binds to RNA polymerase I, causing degradation of the enzyme and potentially affecting transcription factor expression.

ICRF-193

21416-68-2sc-200889
sc-200889A
1 mg
5 mg
$330.00
$898.00
7
(1)

ICRF-193 is a topoisomerase II inhibitor, which can lead to alterations in transcription and gene expression.